Literature DB >> 11803635

[Thyroid metastases].

F Ménégaux1, J P Chigot.   

Abstract

STUDY AIM: The aim of this retrospective study was to report a short series of thyroid metastases and to emphasize their unusual occurrence and their poor prognosis. PATIENTS AND
METHOD: From January 1990 to December 1999, among 619 patients operated for a thyroid malignancy, 14 patients had a thyroid metastasis (2.2%). Mean age of the patients was 66 years (range: 35-81). The thyroid metastasis revealed the primitive tumor (n = 8) or occurred in the follow-up of a cancer already treated (n = 6). The primitive tumor was renal (n = 3), breast (n = 3), lung carcinoma (n = 4) and melanoma (n = 1). In the 3 other patients, the primitive tumor was not detected. The thyroid metastasis was apparently isolated in 13 patients. The surgical procedure was a total (n = 3) or partial (n = 7) thyroidectomy and a cervicotomy with biopsy (n = 4).
RESULTS: Eleven patients died less than one year after the diagnosis of the metastasis. One patient survived 1 year, another 2 years. One patient only was alive 22 years after the diagnosis of his renal tumor and 10 years after total thyroidectomy.
CONCLUSION: Thyroid metastases are clinically very rare and much more frequent at post-mortem examination. They may reveal the primitive cancer but are often detected during the follow-up after treatment of the primitive tumor. When thyroid metastasis is isolated, a total thyroidectomy is justified especially in renal carcinoma, as long-term survivals have been reported.

Entities:  

Mesh:

Year:  2001        PMID: 11803635     DOI: 10.1016/s0003-3944(01)00649-6

Source DB:  PubMed          Journal:  Ann Chir        ISSN: 0003-3944


  13 in total

1.  Synchronous Parotid and Thyroid Gland Metastases from Breast Cancer.

Authors:  Yasemin B Cihan; Kemal Deniz; Mehmet S Yilmaz
Journal:  Breast Care (Basel)       Date:  2011-04-29       Impact factor: 2.860

2.  Synchronous diagnosis of metastatic cancer to the thyroid is associated with poor prognosis.

Authors:  Jeng-Yeou Chen; I-Wen Chen; Chuen Hsueh; Tzu-Chieh Chao; Bing-Ru Gao; Jen-Der Lin
Journal:  Endocr Pathol       Date:  2015-03       Impact factor: 3.943

3.  Metastatic renal cell carcinoma to the thyroid gland 24 years after the primary tumour.

Authors:  Vincenza Di Stasi; Antonio D'Antonio; Alessia Caleo; Luca Valvano
Journal:  BMJ Case Rep       Date:  2013-01-25

Review 4.  Metastatic carcinoma to the thyroid gland: a single institution 20-year experience and review of the literature.

Authors:  Parnian Ahmadi Moghaddam; Kristine M Cornejo; Ashraf Khan
Journal:  Endocr Pathol       Date:  2013-09       Impact factor: 3.943

5.  Metastatic rhabdomyosarcoma of the thyroid gland, a case report.

Authors:  Mohamed T Hafez; Mohamed A Hegazy; Khaled Abd Elwahab; Mohammad Arafa; Islam Abdou; Basel Refky
Journal:  Head Neck Oncol       Date:  2012-05-29

6.  Thyroid metastasis as initial presentation of clear cell renal carcinoma.

Authors:  César Pablo Ramírez-Plaza; Marta Elena Domínguez-López; Francisco Blanco-Reina
Journal:  Int J Surg Case Rep       Date:  2015-03-24

7.  Pitfall in immunohistochemical staining for thyroglobulin in case of thyroid metastasis from lung carcinoma.

Authors:  Napatt Kanjanahattakij; Palapong Chayangsu; Wasana Kanoksil; Sasiphat Chontong; Chutintorn Sriphrapradang
Journal:  Cytojournal       Date:  2015-11-30       Impact factor: 2.091

8.  Thyroid metastasis from nonsmall cell lung cancer.

Authors:  Tariq Namad; Jiang Wang; Ralph Shipley; Nagla Abdel Karim
Journal:  Case Rep Oncol Med       Date:  2013-12-19

Review 9.  Isolated thyroid metastasis revealed an unknown lung adenocarcinoma: a case report.

Authors:  J Khalil; F Elomrani; M Benoulaid; H Elkacemi; T Kebdani; H Errihani; N Benjaafar
Journal:  J Med Case Rep       Date:  2015-09-27

10.  Metastases to the thyroid presenting as a metabolically inactive incidental thyroid nodule with stable size in 15 months.

Authors:  Subhashini Yaturu; Raina A Patel
Journal:  Case Rep Endocrinol       Date:  2014-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.